J&J Plans $1B Investment in PA Cell Therapy Manufacturing Facility
Once fully operational, the Pennsylvania site will employ more than 500 people and make cell therapies for thousands of patients ...
Read moreDetailsOnce fully operational, the Pennsylvania site will employ more than 500 people and make cell therapies for thousands of patients ...
Read moreDetailsSuppliers are investing in production to support deals with AstraZeneca, Bayer, and other drugmakers that are advancing radioisotope-based cancer therapies. ...
Read moreDetailsIncoming PhRMA Chair Paul Hudson, a day before the White House announcement, pledged to work with the administration as the ...
Read moreDetailsAfter the FDA’s decision to reject a review of Moderna’s mRNA-1010 flu shot, executives explain what Americans will miss out ...
Read moreDetailsBristol Myers Squibb is dropping at least $3.5 billion to jointly develop the bispecific antibody, which will race with Summit ...
Read moreDetailsPfizer, Eli Lilly, Novartis, Bristol Myers Squibb, and AstraZeneca are all ramping up the use of AI, but drug discovery ...
Read moreDetailsPhase 2 data demonstrated 17.5-month median overall survival in advanced, chemo-refractory patients with microsatellite stable colorectal cancer (MSS-CRC) Company closed ...
Read moreDetailsSpinal muscular atrophy, SMA, a genetic neuromuscular disorder with progressive muscle wasting because of loss of motor neurons due to ...
Read moreDetailsWASHINGTON, DC - DECEMBER 19: U.S. President Donald Trump speaks during an event in the Roosevelt Room of the White ...
Read moreDetailsHealthcare’s staffing challenge stems from mismatch rather than absolute shortage. Systems should redesign roles, modernise job classes and expand team-based ...
Read moreDetailsThis magazine is newsworthy, analytical, and informative, providing readers with unique and professional content as well as opinions and editorials that will focus on medical and healthcare development. This specialty magazine is also the choice of healthcare professionals and informed readers who need an informed monthly source of news and information in the regional healthcare industry. We aim for excellence in our scientific, health and commercial reports.
© 2023 - ArabHealthWorld all rights reserved